scholarly journals A phase 2, multicenter, placebo-controlled study of single-dose squaric acid dibutyl ester to reduce frequency of outbreaks in patients with recurrent herpes labialis

2020 ◽  
Vol 83 (6) ◽  
pp. 1807-1809 ◽  
Author(s):  
Anne Lynn S. Chang ◽  
Golara Honari ◽  
Linna Guan ◽  
Ludan Zhao ◽  
Maria Alora Palli ◽  
...  
Keyword(s):  
Single Dose ◽  
Squaric Acid ◽  
Controlled Study ◽  
Herpes Labialis ◽  
Phase 2 ◽  
Recurrent Herpes ◽  
Dibutyl Ester

scholarly journals Immune characteristics correlating with HSV‐1 immune control and effect of squaric acid dibutyl ester on immune characteristics of subjects with frequent herpes labialis episodes

2019 ◽  
Vol 7 (1) ◽  
pp. 22-40 ◽  
Author(s):  
Hugh McTavish ◽  
Katherine W. Zerebiec ◽  
Jay C. Zeller ◽  
Laurie L. Shekels ◽  
Mark A. Matson ◽  
...  
Keyword(s):  
Squaric Acid ◽  
Herpes Labialis ◽  
Immune Control ◽  
Dibutyl Ester ◽  
Hsv 1

scholarly journals Immunotherapy of Recurrent Herpes Labialis With Squaric Acid

2017 ◽  
Vol 153 (8) ◽  
pp. 828 ◽  
Author(s):  
Maria Alora Palli ◽  
Hugh McTavish ◽  
Alexa Kimball ◽  
Thomas D. Horn
Keyword(s):  
Squaric Acid ◽  
Herpes Labialis ◽  
Recurrent Herpes

XP-23829, a Novel Fumaric Acid Ester, is Efficacious in Reducing Psoriatic Lesions: Results from a Phase 2 Randomized Controlled Study

2017 ◽  
Vol 1 ◽  
pp. s33 ◽  
Author(s):  
Alice B Gottlieb ◽  
Caitriona Ryan ◽  
Richard Kim ◽  
Aftab Alam ◽  
Sagar Munjal ◽  
...  
Keyword(s):  
Fumaric Acid ◽  
Acid Ester ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Phase 2 ◽  
Randomized Controlled ◽  
Fumaric Acid Ester ◽  
Psoriatic Lesions

Abstract Not Available

Sign in / Sign up

Export Citation Format

Share Document